Yoichi Sakurada

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 24

Top Venues

Pharmaceuticals (Basel, Switzerland)

Medicine

Journal of clinical medicine

Japanese journal of ophthalmology

University of Yamanashi (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Yamanashi

Japan

PHD :: Department of Ophthalmology

Publications

Misa Kimura, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Yuka Kasai, Atsushi Sugiyama, Wataru Kikushima, Daphne Viel Tsuru, Kenji Kashiwagi
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Misa Kimura, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Yuka Kasai, Atsushi Sugiyama, Wataru Kikushima, Daphne Viel Tsuru, Kenji Kashiwagi
Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Atsushi Sugiyama, Kenji Kashiwagi
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Yoshiko Fukuda, Yoichi Sakurada, Mio Matsubara, Yumi Kotoda, Yuka Kasai, Atsushi Sugiyama, Kenji Kashiwagi
Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy. Japanese journal of ophthalmology (2023)
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Atsushi Sugiyama, Kenji Kashiwagi
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Atsushi Sugiyama, Kenji Kashiwagi
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Wataru Kikushima, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Yumi Kotoda, Atsushi Sugiyama, Kenji Kashiwagi
A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Wataru Kikushima, Yoichi Sakurada, Kenji Kashiwagi
Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan. Journal of clinical medicine 11 (23) (2022)
Shuhei Hosoda, Yoichi Sakurada, Taiyo Shijo, Kenji Kashiwagi
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report. Medicine 101 (48) (2022)
Wataru Kikushima, Yoichi Sakurada, Kenji Kashiwagi
Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan. Journal of clinical medicine 11 (23) (2022)
Yoichi Sakurada, Koji Tanaka, Serena Fragiotta
Differentiating drusen and drusenoid deposits subtypes on multimodal imaging and risk of advanced age-related macular degeneration. Japanese journal of ophthalmology (2022)
Shuhei Hosoda, Yoichi Sakurada, Taiyo Shijo, Kenji Kashiwagi
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report. Medicine 101 (48) (2022)
Shuhei Hosoda, Yoichi Sakurada, Taiyo Shijo, Kenji Kashiwagi
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report. Medicine 101 (48) (2022)
Wataru Kikushima, Yoichi Sakurada, Kenji Kashiwagi
Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan. Journal of clinical medicine 11 (23) (2022)
Shuhei Hosoda, Yoichi Sakurada, Taiyo Shijo, Kenji Kashiwagi
Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report. Medicine 101 (48) (2022)
Serena Fragiotta, Solmaz Abdolrahimzadeh, Rosa Dolz-Marco, Yoichi Sakurada, Orly Galor, Gianluca Scuderi
Significance of Hyperreflective Foci as an Optical Coherence Tomography Biomarker in Retinal Diseases: Characterization and Clinical Implications. Journal of ophthalmology 2021 (2021)
Wataru Kikushima, Taiyo Shijo, Yukiko Furuhata, Yoichi Sakurada, Kenji Kashiwagi
Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Yoshiko Fukuda, Yoichi Sakurada, Mio Matsubara, Yuka Hasebe, Atsushi Sugiyama, Wataru Kikushima, Kenji Kashiwagi
Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy. Biomedicines 9 (9) (2021)
Taiyo Shijo, Yoichi Sakurada, Koji Tanaka, Akiko Miki, Seigo Yoneyama, Yumiko Machida, Aya Chubachi, Yu Wakatsuki, Atsushi Sugiyama, Hajime Onoe, Wataru Kikushima, Ryusaburo Mori, Kenji Kashiwagi
Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics. International journal of molecular sciences 22 (8) (2021)
Wataru Kikushima, Yoichi Sakurada, Atsushi Sugiyama, Seigo Yoneyama, Mio Matsubara, Yoshiko Fukuda, Kenji Kashiwagi
Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity. Journal of clinical medicine 10 (5) (2021)
Yumi Shigemoto, Yoichi Sakurada, Yoshiko Fukuda, Mio Matsubara, Ravi Parikh, Kenji Kashiwagi
The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation. Medicine 100 (42) (2021)
Mio Matsubara, Yoichi Sakurada, Atsushi Sugiyama, Yoshiko Fukuda, Ravi Parikh, Kenji Kashiwagi
Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results. PloS one 15 (8) (2020)
Taiyo Shijo, Yoichi Sakurada, Yoshiko Fukuda, Seigo Yoneyama, Atsushi Sugiyama, Mio Matsubara, Wataru Kikushima, Naohiko Tanabe, Ravi Parikh, Kenji Kashiwagi
Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration. International ophthalmology 40 (10) (2020)
Kikushima Wataru, Atsushi Sugiyama, Seigo Yoneyama, Mio Matsubara, Yoshiko Fukuda, Ravi Parikh, Yoichi Sakurada
Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy. PloS one 15 (2) (2020)

Yoichi Sakurada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yoichi Sakurada